{
    "2018-03-02": [
        [
            {
                "time": "2018-03-21",
                "original_text": "Dow Drops 771 Points This Week as Tariffs, Powell Rough Up Stocks",
                "features": {
                    "keywords": [
                        "Dow",
                        "drops",
                        "tariffs",
                        "Powell"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "Biogen, AbbVie Pull Multiple Sclerosis Drug On Inflammation Reports",
                "features": {
                    "keywords": [
                        "Biogen",
                        "AbbVie",
                        "multiple sclerosis",
                        "drug",
                        "inflammation"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "3 Top Dividend Stocks to Buy Right Now",
                "features": {
                    "keywords": [
                        "dividend",
                        "stocks",
                        "buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "Biogen and Abbvie Take Multiple Sclerosis Drug Off Market",
                "features": {
                    "keywords": [
                        "Biogen",
                        "Abbvie",
                        "multiple sclerosis",
                        "drug",
                        "market"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "Notable ETF Inflow Detected - MTUM, BA, ABBV, AMAT",
                "features": {
                    "keywords": [
                        "ETF",
                        "inflow",
                        "MTUM",
                        "BA",
                        "ABBV",
                        "AMAT"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "Nasdaq, S&P 500 Turn Positive But Dow Closes Lower - U.S. Commentary",
                "features": {
                    "keywords": [
                        "Nasdaq",
                        "S&P 500",
                        "Dow",
                        "positive",
                        "lower"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "Multiple Sclerosis Relapse Drug Is Pulled After Patient Safety Concerns",
                "features": {
                    "keywords": [
                        "multiple sclerosis",
                        "drug",
                        "pulled",
                        "safety concerns"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "8 Dividend Payouts That Are Soaring on Tax Cuts",
                "features": {
                    "keywords": [
                        "dividend",
                        "payouts",
                        "soaring",
                        "tax cuts"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "Major Averages Turn Mixed After Seeing Initial Weakness - U.S. Commentary",
                "features": {
                    "keywords": [
                        "major averages",
                        "mixed",
                        "weakness"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTAÂ® (daclizumab) for Relapsing Multiple Sclerosis",
                "features": {
                    "keywords": [
                        "Biogen",
                        "AbbVie",
                        "withdrawal",
                        "ZINBRYTA",
                        "multiple sclerosis"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}